Cytosorbents Corporation (CTSO)
Nasdaq: CTSO · Surgical & Medical Instruments & Apparatus · Princeton, NJ · filing with the SEC since 2004
Who runs Cytosorbents Corporation
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Chan Phillip P.
Chief Executive Officer. First filing Aug 2008, latest Sep 16, 2026, 18 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
13 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chan Phillip P. | Chief Executive Officer | Aug 2008 | Sep 16, 2026 | none |
| Capponi Vincent | President and COO | Jul 2006 | Sep 16, 2026 | none |
| Mariani Peter J | Chief Financial Officer | Aug 2024 | Jun 16, 2026 | none |
| Deliargyris Efthymios | Chief Medical Officer | Apr 2020 | Aug 8, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Sobel Alan D. | director | Apr 2015 | Sep 16, 2026 | none |
| Bator Michael G. | director | Jul 2015 | Aug 8, 2025 | none |
| Jones Edward Raymond | director | Apr 2007 | Aug 8, 2025 | none |
| Kim Jiny | director | Apr 2022 | Aug 8, 2025 | none |
Earlier names on the record6, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.